Jane Huang, outgoing hematology CMO at BeiGene
March 4, 2022 10:57 AM ESTUpdated March 9, 12:53 PM
People

BeiGene's hema­tol­ogy CMO is on her way out amid mar­ket tur­moil

Paul Schloesser

Associate Editor

Af­ter six years in the role, BeiGene’s hema­tol­ogy CMO has an­nounced her up­com­ing de­par­ture.

The biotech kept it short in an 8-K filed yes­ter­day, but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

To spin off or not to spin off? Gala­pa­gos backpedals on sep­a­ra­tion plans, CEO Paul Stof­fels ex­its ear­ly

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

Dutch biotech gets $146M for late-stage tri­als in three meta­bol­ic dis­or­ders

Lack of de­tail in Trump's drug price plan rais­es more ques­tions than an­swers

Phar­ma in­vestors brush off Trump’s ‘most fa­vored na­tion’ plan as stocks rise

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

A service from the Financial Times